Outlook on the Nuclear Medicine Global Market to 2028: Use of Radiopharmaceuticals in Neurological Applications Presents Opportunities - Yahoo Finance

The survey connected atomic medicine marketplace covers the investigation of the starring geographies specified arsenic North America, Europe, Asia-Pacific, and RoW for the play of 2020 to 2028.

The study connected atomic medicine marketplace is simply a broad survey and presumption of drivers, restraints, opportunities, request factors, marketplace size, forecasts, and trends successful the planetary atomic medicine marketplace implicit the play of 2020 to 2028. Moreover, the study is simply a corporate presumption of superior and secondary probe findings.

Porter's 5 forces exemplary successful the study provides insights into the competitory rivalry, supplier and purchaser positions successful the marketplace and opportunities for the caller entrants successful the planetary atomic medicine marketplace implicit the play of 2020 to 2028. Further, IGR- Growth Matrix gave successful the study brings an penetration into the concern areas that existing oregon caller marketplace players tin consider.

Report Findings

What does this Report Deliver?
1. Comprehensive investigation of the planetary arsenic good arsenic determination markets of the atomic medicine market.
2. Complete sum of each the segments successful the atomic medicine marketplace to analyse the trends, developments successful the planetary marketplace and forecast of marketplace size up to 2028.
3. Comprehensive investigation of the companies operating successful the planetary atomic medicine market. The institution illustration includes investigation of merchandise portfolio, revenue, SWOT investigation and latest developments of the company.
4. IGR- Growth Matrix presents an investigation of the merchandise segments and geographies that marketplace players should absorption to invest, consolidate, grow and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Nuclear Medicine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 interaction connected the Nuclear Medicine Market
3.4. Porter's Five Forces Analysis
3.5. IGR-Growth Matrix Analysis
3.5.1. IGR-Growth Matrix Analysis by Product
3.5.2. IGR-Growth Matrix Analysis by Application
3.5.3. IGR-Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Nuclear Medicine Market

4. Nuclear Medicine Market Macro Indicator Analysis

5. Global Nuclear Medicine Market by Product
5.1. Diagnostic Products
5.1.1. SPECT
5.1.2. PET
5.2. Therapeutic Products
5.2.1. Alpha Emitters
5.2.2. Beta Emitters
5.2.3. Brachytherapy

6. Global Nuclear Medicine Market by Application
6.1. Cardiology
6.2. Neurology
6.3. Oncology
6.4. Thyroid
6.5. Lymphoma
6.6. Others

7. Global Nuclear Medicine Market by Region 2022-2028
7.1. North America
7.1.1. North America Nuclear Medicine Market by Product
7.1.2. North America Nuclear Medicine Market by Application
7.1.3. North America Nuclear Medicine Market by Country
7.2. Europe
7.2.1. Europe Nuclear Medicine Market by Product
7.2.2. Europe Nuclear Medicine Market by Application
7.2.3. Europe Nuclear Medicine Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Nuclear Medicine Market by Product
7.3.2. Asia-Pacific Nuclear Medicine Market by Application
7.3.3. Asia-Pacific Nuclear Medicine Market by Country
7.4. RoW
7.4.1. RoW Nuclear Medicine Market by Product
7.4.2. RoW Nuclear Medicine Market by Application
7.4.3. RoW Nuclear Medicine Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape successful the Global Nuclear Medicine Market
8.2. Companies Profiled
8.2.1. GE Healthcare
8.2.2. Mallinckrodt plc.
8.2.3. Norgine B.V.
8.2.4. Medtronic, Inc.
8.2.5. Bayer AG
8.2.6. Cardinal Health, Inc.
8.2.7. Lantheus Medical Imaging, Inc.
8.2.8. IBA Group
8.2.9. Nordion, Inc.
8.2.10. Advanced Accelerator Applications S.A.